hear3445

Nick Fitzgerald has served as HHTM’s Chief Marketing Officer for the past 3 years. He is the President and Owner of AuDSEO, a full service digital marketing agency. With over 15 years of digital marketing experience, Nick is a highly data-driven marketer, with expertise in search engine optimization, digital analytics and forensics, social media, digital advertising, and web development. He has been involved in the construction and optimization of nearly 1,000 web presences, including some of the largest Fortune 500 companies.
Featured image for “ON Semiconductor Unveils New Development Suite to Make it Easier for Manufacturers to Build Wireless-Enabled Hearing Aids”
Oct. 18, 2017

ON Semiconductor Unveils New Development Suite to Make it Easier for Manufacturers to Build Wireless-Enabled Hearing Aids

hear3445
NUREMBURG, GERMANY — ON Semiconductor, a leading supplier of semiconductor-based solutions, unveiled a new development toolkit for manufacturers of hearing aids at the 2017 EUHA convention in Germany. The Ezairo® Preconfigured Suite (Pre Suite) is based on the company’s Ezairo 7100 Digitial Signal Processor (DSP), and includes development software, firmware bundles, and a Software Development Kit (SDK) for manufacturers to
Featured image for “Audiology Listed Among Highest Paying Jobs for People Who Want to Work Less Than 40 Hours Per Week”
Oct. 16, 2017

Audiology Listed Among Highest Paying Jobs for People Who Want to Work Less Than 40 Hours Per Week

hear3445
According to Business Insider, audiology was rated among the top careers in 2017 that provide good pay and also offer a good work-life balance. The top 16 careers in this year’s list were chosen from among 478 occupations in the US, using the Minnesota Population Center’s 2015 American Community Survey Integrated Public Use Microdata Series. According to the survey data,
Featured image for “New Study Finds No Relationship Between Common Recreational Noise Exposure, “Hidden Hearing Loss””
Oct. 10, 2017

New Study Finds No Relationship Between Common Recreational Noise Exposure, “Hidden Hearing Loss”

hear3445
DALLAS, TEXAS — According to a recently published study, no relationship has been found between common recreational noise exposure and so-called “hidden hearing loss”. The study, conducted by researchers at the University of Texas (UT) Dallas, was published last month in Frontiers in Neuroscience. Previously, researchers have proposed that recreational noise exposure may result in damage between the sensory hair
Featured image for “Sound Pharmaceuticals Says Positive Results from Phase 1b Clinical Trial in Meniere’s Disease, Starting Phase 2b”
Oct. 07, 2017

Sound Pharmaceuticals Says Positive Results from Phase 1b Clinical Trial in Meniere’s Disease, Starting Phase 2b

hear3445
SEATTLE, WASHINGTON — Sound Pharmaceuticals, a Seattle-based biotech firm, announced this week that it has achieved positive topline results from its recently completed Phase 1b SPI-1005-151 clinical trial involving Meniere’s Disease (MD) patients. SPI-1005 is the company’s investigational new drug, which mimics and induces Glutathione Peroxidase (GPx), which has been shown to reduce the swelling or edema of the inner ear
Featured image for “Early Hearing Detection Bill Passes Congress, Awaits President’s Signature”
Oct. 04, 2017

Early Hearing Detection Bill Passes Congress, Awaits President’s Signature

hear3445
WASHINGTON, DC — Following the lead of the US Senate, which passed the legislation on September 7th, the House passed the bipartisan Early Hearing Detection and Intervention Act on October 3rd. The legislation, sponsored by Reps. Brett Guthrie (R-KY) and Doris Matsui (D-CA), would reauthorize EHDI programs for the next five years. According to the American Academy of Audiology (AAA), after
Featured image for “Rhode Island Establishes Commission to Study Early Intervention for Children with Hearing Loss”
Oct. 02, 2017

Rhode Island Establishes Commission to Study Early Intervention for Children with Hearing Loss

hear3445
PROVIDENCE, RHODE ISLAND — In legislation approved by the Rhode Island General Assembly, a joint legislative commission has been established to determine whether and how the state can better serve children with hearing loss. The special commission will be made up of 24 members, including legislators, healthcare professionals and representatives from organizations and agencies that serve children with hearing loss.
Featured image for “Montana Radar Company Receives $2 Million Innovation Grant for Hearing Aid Tech”
Sep. 29, 2017

Montana Radar Company Receives $2 Million Innovation Grant for Hearing Aid Tech

hear3445
BOZEMAN, MONTANA — Flat Earth Inc., a Montana-based radar development company, was recently awarded a $2 million Small Business Innovation Research (SBIR) grant from the U.S. Small Business Administration. According to the company, the grant will used to help further develop the open speech platform — an algorithm the company developed to improve the quality of hearing aid devices. In
Featured image for “Auris Medical Announces it Has Completed Enrollment for Phase 3 Trial of Tinnitus Drug, Keyzilen”
Sep. 24, 2017

Auris Medical Announces it Has Completed Enrollment for Phase 3 Trial of Tinnitus Drug, Keyzilen

hear3445
ZUG, SWITZERLAND — Biopharmaceutical company Auris Medical Holdings announced today that it  has completed patient enrollment in the Phase 3 TACTT3 clinical trial of Keyzilen, in acute and post-acute peripheral (inner ear) tinnitus. The company’s investigative drug, Keyzilen, is esketamine gel for intratympanic injection, intended for acute peripheral tinnitus following cochlear injury or otitis media in adults. The drug received Fast
Featured image for “After Disappointing Results on Phase 3 Trial of Meniere’s Drug, Otonomy Lays off Staff, Suspends Further Trials in 2017”
Sep. 21, 2017

After Disappointing Results on Phase 3 Trial of Meniere’s Drug, Otonomy Lays off Staff, Suspends Further Trials in 2017

hear3445
SAN DIEGO, CALIFORNIA — Following disappointing AVERTS-1 Phase 3 trial results of OTIVIDEX in Ménière’s disease patients, Otonomy, Inc., a US-based biopharmaceutical firm, announced that the company is laying off one-third of its noncommercial staff and will not initiate any further clinical trials through the end of 2017.  With the announcement, the timing for initiation of a Phase 2 clinical
Featured image for “Bill Austin Named As the First Goodwill Global Ambassador for Ear and Hearing Health”
Sep. 19, 2017

Bill Austin Named As the First Goodwill Global Ambassador for Ear and Hearing Health

hear3445
NEW YORK — Starkey Hearing Technologies CEO Bill Austin, was named as the Goodwill Global Ambassador for Ear and Hearing Health by the International Federation for Peace & Sustainable Development (IFPSD) last week during an event at the United Nations (UN) headquarters in New York. The IFPSD is a non-profit organization that promotes and supports the UN’s commitment to international